论文部分内容阅读
1 临床资料 本组20例重症肺心病中,男13例,女7例,年龄36～82岁。其基础疾病为慢支、肺气肿14例,支气管哮喘1例,胸廓畸形2例,支气管扩张1例,肺间质纤维化2例。20例病人入院前均有7～15d的应用抗菌素及大量利尿剂史。入院时病人主要表现为:乏力、精神差、淡漠,其中18例表现为嗜睡,2例表现为抽搐。入院后测血浆渗透压270～280mmol/L者12例,256～269 mmol/L者8例;其中血钠均在118～132mmol/L之间、血氯均在68～98之间、血钾<3.5 mmol/L者7例,二重酸碱失衡者17例,三重酸碱紊乱者3例。治疗:除常规给予吸氧、抗感染、保持呼吸道通畅、合理使用呼吸兴奋剂、
1 Clinical data The group of 20 patients with severe pulmonary heart disease, 13 males and 7 females, aged 36 to 82 years. The underlying diseases are chronic bronchitis, emphysema in 14 cases, bronchial asthma in 1 case, thoracic deformity in 2 cases, bronchiectasis in 1 case, pulmonary interstitial fibrosis in 2 cases. 20 patients before admission were 7 to 15 days of antibiotics and a large number of diuretics history. The main manifestations of patients on admission were: fatigue, poor spirits, indifference, of which 18 cases showed drowsiness, 2 cases showed convulsions. After admission, plasma osmolality was measured in 270 patients with 280mmol / L in 12 cases, 256 ~ 269 mmol / L in 8 cases; the serum sodium were between 118 ~ 132mmol / L, blood levels were between 68 to 98, potassium <3.5 mmol / L in 7 cases, double acid-base imbalance in 17 cases, triple acid-base disorders in 3 cases. Treatment: In addition to conventional oxygen, anti-infection, keep the airway open, the rational use of respiratory stimulants,